Seth A Rosenthal

Summary

Affiliation: Radiological Associates of Sacramento
Country: USA

Publications

  1. ncbi Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-ris
    Seth A Rosenthal
    Radiation Oncology Center, Radiological Associates of Sacramento, Sacramento, CA 95815, USA
    Int J Radiat Oncol Biol Phys 73:672-8. 2009
  2. ncbi Treatment strategies for high-risk locally advanced prostate cancer
    Seth A Rosenthal
    Radiation Oncology Centers, Radiological Associates of Sacramento, 1500 Expo Parkway, Sacramento, CA 95815, USA
    Nat Rev Urol 7:31-8. 2010
  3. ncbi American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate cancer
    Seth A Rosenthal
    Radiation Oncology Centers, Radiological Associates of Sacramento, Sacramento, CA 95815 4227, USA
    Int J Radiat Oncol Biol Phys 79:335-41. 2011
  4. ncbi Central abdominal uptake of indium-111 capromab pendetide (ProstaScint) predicts for poor prognosis in patients with prostate cancer
    Michael K Haseman
    Radiological Associates of Sacramento, Sacramento, California 95815, USA
    Urology 70:303-8. 2007
  5. ncbi On using 3D γ-analysis for IMRT and VMAT pretreatment plan QA
    Chuan Wu
    Radiation Oncology Centers ROC, Radiological Associates of Sacramento RAS, Sacramento, CA 95815, USA
    Med Phys 39:3051-9. 2012

Detail Information

Publications5

  1. ncbi Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-ris
    Seth A Rosenthal
    Radiation Oncology Center, Radiological Associates of Sacramento, Sacramento, CA 95815, USA
    Int J Radiat Oncol Biol Phys 73:672-8. 2009
    ....
  2. ncbi Treatment strategies for high-risk locally advanced prostate cancer
    Seth A Rosenthal
    Radiation Oncology Centers, Radiological Associates of Sacramento, 1500 Expo Parkway, Sacramento, CA 95815, USA
    Nat Rev Urol 7:31-8. 2010
    ..Improved radiotherapy techniques that allow for dose escalation, and new systemic therapy approaches such as adjuvant chemotherapy, present promising future therapeutic alternatives for patients with high-risk prostate cancer...
  3. ncbi American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate cancer
    Seth A Rosenthal
    Radiation Oncology Centers, Radiological Associates of Sacramento, Sacramento, CA 95815 4227, USA
    Int J Radiat Oncol Biol Phys 79:335-41. 2011
    ..Adherence to these practice guidelines can be part of ensuring quality and safety in a successful prostate brachytherapy program...
  4. ncbi Central abdominal uptake of indium-111 capromab pendetide (ProstaScint) predicts for poor prognosis in patients with prostate cancer
    Michael K Haseman
    Radiological Associates of Sacramento, Sacramento, California 95815, USA
    Urology 70:303-8. 2007
    ..We report the outcomes data from a cohort of patients with CAU on CP images obtained for staging...
  5. ncbi On using 3D γ-analysis for IMRT and VMAT pretreatment plan QA
    Chuan Wu
    Radiation Oncology Centers ROC, Radiological Associates of Sacramento RAS, Sacramento, CA 95815, USA
    Med Phys 39:3051-9. 2012
    ..To investigate using 3D γ analysis for IMRT and VMAT QA...